US Patent 7625507 Extrusion process for forming chemically stable drug multiparticulates

Patent 7625507 was granted and assigned to Pfizer Limited on December, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

76255070

Patent Inventor Names

Scott B. McCray0

Leah E. Appel0

Marshall D. Crew0

Roderick J. Ray0

David D. Newbold0

David K. Lyon0

Dwayne T. Friesen0

James B. West0

...

Date of Patent

December 1, 2009

Patent Application Number

110041650

Date Filed

December 3, 2004

Patent Primary Examiner

‌

Mary Lynn F Theisen

Patent abstract

Reduced levels of drug degradation in drug-containing multiparticulates are obtained by an extrusion/melt-congeal process.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7625507 Extrusion process for forming chemically stable drug multiparticulates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API